Search

everythinglearnresearchcommunity

for

Search:↓

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Low zinc levels may be linked to the return of gynecologic cancers.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Reporter characteristics affect detection of hair loss from cancer therapy.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

CEC levels may be a useful marker for predicting prostate cancer progression.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Korean patients with rosacea are more likely to have other health conditions.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

Micrografts and minigrafts are safe and effective for hair transplantation in facial and scalp reconstruction, providing high patient satisfaction.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

UC.145 may be a new biomarker for predicting gastric cancer.

Breast cancer may be detectable through changes in scalp hair lipids.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Families help manage chemotherapy side effects at home by providing preferred foods, keeping hair short, assisting with routines, and ensuring hydration.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.